Johnson & Johnson (NYSE:JNJ)
| 133.12 Delayed Data As of Apr 02 |  +4.31 / +3.35%Today’s Change | 109.16 Today|||52-Week Range 154.50 | -8.74% Year-to-Date |
Latest JNJ News | Press Releases
Today’s Trading
| Previous close | 128.81 |
| Today’s open | 129.00 |
| Day’s range | 127.22 - 133.95 |
| Volume | 11,594,456 |
| Average volume (3 months) | 9,317,583 |
| Market cap | $324.7B |
Data as of 4:40pm ET, 04/02/2020
Growth & Valuation
| Earnings growth (last year) | +0.28% |
| Earnings growth (this year) | +1.91% |
| Earnings growth (next 5 years) | +5.96% |
| Revenue growth (last year) | +0.71% |
| P/E ratio | 23.7 |
| Price/Sales | 4.76 |
| Price/Book | 5.45 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| MRKMerck | +3.03 | +4.11% |
| NVSNovartis | +2.62 | +3.24% |
| PFEPfizer | +1.11 | +3.50% |
| LLYEli Lilly and Co | +5.73 | +4.20% |
Data as of 5:30pm ET, 04/02/2020
Financials
| Next reporting date | April 14, 2020 |
| EPS forecast (this quarter) | $2.09 |
| Annual revenue (last year) | $82.1B |
| Annual profit (last year) | $15.1B |
| Net profit margin | 18.41% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters New Brunswick, New Jersey |
Forecasts
